<DOC>
	<DOC>NCT01647308</DOC>
	<brief_summary>The purpose of this study is to evaluate the effects of ISIS ISIS-APOCIIIRX on Triglyceride Levels and Insulin Sensitivity in Subjects with Type 2 Diabetes on stable treatment with metformin.</brief_summary>
	<brief_title>Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>BMI &gt;/= 25 to &lt;/= 40 kg/m2 Type 2 Diabetes Mellitus and on a stable dose of metformin Hypertriglyceridemia Significant abnormalities in medical history, clinical examination or clinical testing Use of oral antidiabetic medication other than metformin within 3 months prior to dosing History of outpatient insulin use for more than 2 weeks in the last year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>